Press Releases

Research and Markets: Menopause Partnering 2007-2013

Monday 20 May,2013

Research and Markets: Motor Neurone Disease Partnering 2007-2013

Monday 20 May,2013

XenoPort Reports Top-Line Results of Phase 3 Trial of Arbaclofen Placarbil for Spasticity in Multiple Sclerosis Patients

Monday 20 May,2013

Synagevas Sebelipase Alfa Receives Breakthrough Therapy Designation for Early Onset LAL Deficiency from the U.S. Food and Drug Administration

Monday 20 May,2013

Affymetrix Appoints Gavin Wood as Executive Vice President and Chief Financial Officer

Monday 20 May,2013

Emergent BioSolutions to Webcast Presentation at Jefferies 2013 Global Healthcare Conference

Monday 20 May,2013

PRIUM Seeks Functional Restoration and Pain Management Centers for Its Workers’ Compensation Payer-Clients

Monday 20 May,2013

R-Tech Ueno: Start of the Patient Enrollment of a Phase I/II Clinical Study of Recombinant Human Serum Albumin-Containing Ophthalmic Solution (Development Code: RU-101) in US for the Treatment of Severe Dry Eye

Monday 20 May,2013

Elan Announces Proposed Offering of US$800.0 Million in Aggregate Principal Amount of Senior Notes Due 2021

Monday 20 May,2013

Elan Announces Transactions: Decisively Transforming the Company

Monday 20 May,2013

EpiCept Reports First Quarter 2013 Operating and Financial Results

Sunday 19 May,2013

Cubist Achieves Top Biotech Ranking in Globe 100 List

Sunday 19 May,2013

Merck to Present at the UBS Global Healthcare Conference

Sunday 19 May,2013

Research and Markets: Allergic Rhinitis Partnering 2007-2013 Contains Over 120 Links to Online Copies of Actual Allergic Rhinitis Deals and Contract Documents

Sunday 19 May,2013

Research and Markets: Pneumonia Partnering 2007-2013

Sunday 19 May,2013

Puma Biotechnology Comment on Trading Activity

Sunday 19 May,2013

Research and Markets: Gastrointestinal Symptoms Partnering 2007-2013 Report Contains Over 100 Links to Online Copies of Actual Gastrointestinal Symptoms Deals and Contract Documents

Sunday 19 May,2013

Gilead Sciences to Present at the 2013 UBS Global Healthcare Conference on Monday, May 20

Sunday 19 May,2013

Research and Markets: Disease and Therapy Review 2013: Major Depressive Disorder

Sunday 19 May,2013

Research and Markets: Gastroesophageal Reflux Disease (GERD): Disease and Therapy Review - 2013

Sunday 19 May,2013

Research and Markets: Disease and Therapy Review: Insomnia - 2013

Sunday 19 May,2013

Truven Health Analytics Honors MGM Resorts International for Improving Healthcare

Sunday 19 May,2013

Discovery, Preclinical & Clinical Stage Dealmaking Reviewed in New CurrentPartnering Report Available at MarketPublishers.com

Sunday 19 May,2013

Walgreens and Alliance Boots Receive Regulatory Clearance to Make Equity Investment in AmerisourceBergen

Sunday 19 May,2013

AmerisourceBergen Receives Regulatory Approval of Walgreens and Alliance Boots Equity Investment

Sunday 19 May,2013

Research and Markets: 2013 Disease and Therapy Review: Hypercholesteremia

Sunday 19 May,2013

Biopharmaceutical Equipment and Technology Assets of Palo Alto, CA Campus of Pharmaceutical Developer Affymax to be Auctioned by Heritage Global Partners and Maynards June 13-14

Sunday 19 May,2013

Research and Markets: Drug Evaluation Report: Sanofis and Genzymes Aubagio (Teriflunomide) (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Sunday 19 May,2013

Impax Laboratories Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.

Sunday 19 May,2013

Research and Markets: Gilenya (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Sunday 19 May,2013

BioLineRx Enters into “At-The-Market” Offering Agreement with Stifel, Nicolaus & Company

Sunday 19 May,2013

Global Health, Development and Business Leaders Announce New Innovative Financing Partnership to Deliver Essential Health Supplies More Quickly and Efficiently

Sunday 19 May,2013

XenoPort Provides Update on Availability of Horizant

Sunday 19 May,2013

Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015

Sunday 19 May,2013

GfK to Share Insights on Personalized Medicine, Complex Treatment Regimens At PBIRG Annual Meeting

Friday 17 May,2013

Research and Markets: Gastric Cancer Partnering 2007-2013

Friday 17 May,2013

InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to Be Held on May 23rd

Friday 17 May,2013

Acorda Therapeutics’ Legal Department Recognized on Best Legal Departments List by Corporate Counsel Magazine

Friday 17 May,2013

Harbor Island Development Corp. Announces Strong Response for the NxUltra Campaign in Support of Further Expansion of Marketing Efforts

Friday 17 May,2013

Santarus Announces UCERIS (budesonide) Poster Presentations at Digestive Disease Week Meeting

Friday 17 May,2013

Tech Council of Maryland Announces Winners of 2013 Tech Awards at Annual Dinner and Celebration

Friday 17 May,2013

Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2013

Friday 17 May,2013

Taro to Announce Results for Year Ended March 31, 2013

Friday 17 May,2013

Bristol-Myers Squibb Announces Intention to Voluntarily Delist Preferred Stock

Friday 17 May,2013

Dialysis Equipment & Services Market Examined by Kalorama Information in New Report Now Available at MarketPublishers.com

Friday 17 May,2013

Alkermes to Host Conference Call to Discuss Financial Results for Fiscal Year 2013

Friday 17 May,2013

New Para IV Plus Database Prepared by MP Advisors Now Available at MarketPublishers.com

Friday 17 May,2013

QPharma Appoints Chief Medical Officer

Friday 17 May,2013

Regulatory Harmonization Institute Launches Workshops for Algerian Ministry of Health, Programs for Emerging Markets: Forums Address Drug/Medical Device Regulatory Requirements

Friday 17 May,2013

Cellectis: TAL-effector nuclease: Issuance by the USPTO of Two New Patents

Friday 17 May,2013

Research and Markets: Antibody Partnering Terms and Agreements 2013

Friday 17 May,2013

Research and Markets: Alzheimer Disease - New Drugs, Markets and Companies - Updated 2013 Edition

Friday 17 May,2013

Tetraphase Pharmaceuticals to Present at the Annual UBS Global Healthcare Conference

Friday 17 May,2013

Research and Markets: Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2013

Friday 17 May,2013

EuroMedtech™ 2013 Helps Create Collaborative Pathways to Getting Medtech Innovation to Market

Friday 17 May,2013

Research and Markets: PharmaPoint Analysis: Multiple Sclerosis - US Drug Forecast and Market Analysis to 2022

Friday 17 May,2013

Alliance Life Sciences Sponsors ISPOR 18th Annual International Meeting, Presents Study Highlighting Optimal Solutions for Pricing Pharmaceuticals

Friday 17 May,2013

PerkinElmer Launches New OneSource® Laboratory Consulting Services to Drive Improved Laboratory Efficiencies

Friday 17 May,2013

Research and Markets: Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022

Friday 17 May,2013

Promedior to Present Clinical Data on Lead Drug Candidate, PRM-151, in Patients with IPF at the ATS 2013 Annual Meeting

Friday 17 May,2013

Obtaining a Sufficient Budget is a Top Challenge Facing New Product Planning Teams

Friday 17 May,2013

AmerisourceBergen Elects Lon R. Greenberg to Its Board of Directors

Thursday 16 May,2013

FDA Approves APOQUEL® (oclacitinib tablet) to Control Itch and Inflammation in Allergic Dogs

Thursday 16 May,2013

NPS Pharmaceuticals President and CEO Dr. Francois Nader Recognized as Regional Finalist for Ernst & Young Entrepreneur of the Year® 2013

Thursday 16 May,2013

Clovis Oncology Announces Clinical Data to be Presented at ASCO Annual Meeting 2013

Thursday 16 May,2013

Transgenomic Announces Global Availability of CRC RAScan™ Mutation Detection Test for Use in Patients with Metastatic Colorectal Cancer to Help Identify Appropriate Treatment

Thursday 16 May,2013

Research and Markets: Asthma Partnering 2007-2013

Thursday 16 May,2013

Research and Markets: Depression Partnering 2007-2013

Thursday 16 May,2013

Research and Markets: Systemic Lupus Erythematosus Partnering 2007-2013

Thursday 16 May,2013

Research and Markets: Mucositis Partnering 2007-2013

Thursday 16 May,2013

Research and Markets: AIDS Partnering 2007-2013

Thursday 16 May,2013

Illumina Launches BaseSpace® Apps

Thursday 16 May,2013

Derma Sciences Reports First Quarter 2013 Financial Results

Thursday 16 May,2013

ImmunoCellular Therapeutics Announces Issuance of Key Patent Covering ICT-107 Cancer Vaccine Target

Thursday 16 May,2013

Senesco Technologies Reports Second Quarter Fiscal 2013 Financial Results

Thursday 16 May,2013

Alkermes Elects Nancy Wysenski to Board of Directors

Thursday 16 May,2013

InVivo Therapeutics Sponsors 8th Annual Working 2 Walk Spinal Cord Injury Symposium

Thursday 16 May,2013

Bayer Facebook Photo Contest Takes Flight for the Arrival of Anniversary Airship in United States

Thursday 16 May,2013

NextPharma completes executive management team with the appointment of Jean Cuiné as Chief Scientific Officer

Thursday 16 May,2013

Dyax HAE Allies℠ Awards Program Launches on Second Annual Hereditary Angioedema (HAE) Day – a Global Event to Raise Awareness of HAE

Thursday 16 May,2013

Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting

Thursday 16 May,2013

Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday May 23, 2013 at 9:00 AM Eastern; Webcast Will Be Available

Thursday 16 May,2013

Infinity Announces Clinical Data to Be Presented at ASCO and ICML

Thursday 16 May,2013

Gilead Announces Response Data from Phase 2 Study of Idelalisib for Previously Untreated Chronic Lymphocytic Leukemia

Thursday 16 May,2013

Targeted Medical Pharma Reports 2013 First Quarter Results

Thursday 16 May,2013

Merck Prices $ 6.5 Billion Debt Offering

Thursday 16 May,2013

Synta Announces Presentations at the 2013 American Society for Clinical Oncology (ASCO) Annual Meeting

Thursday 16 May,2013

AVEO and Astellas Announce Presentations of Tivozanib Clinical Data at 2013 American Society of Clinical Oncology Annual Meeting

Thursday 16 May,2013

Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer

Thursday 16 May,2013

NanoString Technologies Announces Oral Study Presentation of the Prosigna™ Assay in Postmenopausal Node-Positive Breast Cancer at the 2013 Annual American Society of Clinical Oncology

Thursday 16 May,2013

Elan Announces Publication of Response Document

Thursday 16 May,2013

SunLink Health Systems, Inc. Announces Fiscal 2013 Third Quarter and Nine Months Results

Thursday 16 May,2013

Onconova Announces Presentation of Oral Rigosertib Safety and Activity Data in Lower Risk Myelodysplastic Syndromes at the 2013 ASCO Annual Meeting

Thursday 16 May,2013

Eutropics Pharmaceuticals to Present Data on Personalized Diagnostic for AML Patient Management at ASCO 2013

Thursday 16 May,2013

CORRECTING and REPLACING Celator® Pharmaceuticals Announces Business Update and Fiscal First Quarter 2013 Operational and Financial Results

Thursday 16 May,2013

Celator® Pharmaceuticals Announces Business Update and Fiscal First Quarter 2013 Operational and Financial Results

Thursday 16 May,2013

WIL Research Partners with Three S Japan to Expand Full Portfolio of Global Safety Assessment Services to the Japanese Market

Thursday 16 May,2013

Reminder: Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meeting

Thursday 16 May,2013

Relypsa Announces Appointment of John Orwin as Chief Executive Officer

Thursday 16 May,2013

Navidea Biopharmaceuticals Signs Manufacturing and Supply Agreement with Nordion

Thursday 16 May,2013

Nordion Signs Contract Manufacturing Agreement with Navidea Biopharmaceuticals

Thursday 16 May,2013

Research and Markets: Chinese Markets for Stabilizers to 2021

Thursday 16 May,2013

Research and Markets: Crohns Disease - Disease and Therapy Review 2013 Covers Dosing and Treatment Costs

Thursday 16 May,2013

Research and Markets: Disease and Therapy Review: Urinary Incontinence - 2013 Study

Thursday 16 May,2013

Research and Markets: 2013 Disease and Therapy Review: Multiple Sclerosis Report Gives a Succinct Analysis

Thursday 16 May,2013

Bristol-Myers Squibb Advances Leadership Position in Immuno-Oncology with Data to be Presented at 2013 American Society of Clinical Oncology (ASCO) Annual Meeting

Thursday 16 May,2013

Santarus Announces Exercise in Full of Option to Purchase Additional Shares and Completion of Secondary Common Stock Offering

Thursday 16 May,2013

Bristol-Myers Squibb to Hold Investor Teleconference to Discuss ASCO Highlights

Thursday 16 May,2013

New ISR Phase I Report Shows Rise in Study Complexity and Use of Patient Populations

Thursday 16 May,2013

ARIAD Announces Data Presentations and Webcast of Investor Briefing at the 2013 ASCO Annual Meeting

Thursday 16 May,2013

Foundation Medicine to Present Clinical Data on its FoundationOne™ Cancer Genomic Profile at the 2013 ASCO Annual Meeting

Thursday 16 May,2013

Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference

Thursday 16 May,2013

Research and Markets: Tcelna (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Thursday 16 May,2013

Research and Markets: Avonex (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Thursday 16 May,2013

Research and Markets: BG-12 (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Thursday 16 May,2013

Research and Markets: Disease and Therapy Review 2013: Senile Dementia

Thursday 16 May,2013

Studies Reaffirm Global Green’s Poultry Vaccine Meets Need of Preventive Method Against Salmonella at the Farm Level

Thursday 16 May,2013

EXP Pharmaceutical Services Corp.® and AnewMed, Inc. Announce Partnership to Immediately Make Available The Medical Device Renewal Program

Thursday 16 May,2013

Research and Markets: The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities

Wednesday 15 May,2013

Research and Markets: China Pharmaceutical Guidebook Series 4 2013 - Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration

Wednesday 15 May,2013

Research and Markets: China Pharmaceutical Guidebook Series 3 2013 Edition - Material and Clinical Trial Requirements of Application and Approval for Imported Drug Registration

Wednesday 15 May,2013

Research and Markets: China Pharmaceutical Guidebook Series 2013 Edition Latest Chinese Regulations for Imported Drug Registration: A Comprehensive Guidebook for Foreign Pharmaceutical Companies

Wednesday 15 May,2013

Elixir Medical Receives CE Mark Approval for the Fully Bioresorbable DESolve® Novolimus Eluting Coronary Scaffold System

Wednesday 15 May,2013

Sucampo to be Added to the NASDAQ Biotechnology Index

Wednesday 15 May,2013

Tokai Pharmaceuticals Announces $35.5 Million Series E Financing

Wednesday 15 May,2013

Hawaii Rx Drug Summit Examines the State’s Prescription Drug Problem

Wednesday 15 May,2013

Synageva BioPharma™ Joins the International MPS Network in Support of MPS Awareness Day 2013

Wednesday 15 May,2013

Acorda Therapeutics to Present at the UBS Global Healthcare Conference

Wednesday 15 May,2013

Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO

Wednesday 15 May,2013

FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer

Wednesday 15 May,2013

BioTime Appoints Franklin Berger to Board of Directors

Wednesday 15 May,2013

Truven Health Analytics CEO Mike Boswood Discusses Future of Healthcare

Wednesday 15 May,2013

Abraham, Fruchter & Twersky, LLP Announces That a Class Action Lawsuit Has Been Filed against AVEO Pharmaceuticals, Inc.

Wednesday 15 May,2013

OncoMed Pharmaceuticals Initiates Phase 1b/2 Clinical Trial of Anti-Cancer Stem Cell Therapeutic OMP-59R5 (Anti-Notch2/3) in Small Cell Lung Cancer (SCLC) and Amends Phase1b/2 Pancreatic Cancer Trial

Wednesday 15 May,2013

Codexis to Present at 2013 UBS Global Healthcare Conference

Wednesday 15 May,2013

ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock

Wednesday 15 May,2013

Bristol-Myers Squibb to Present at UBS Global Health Care Conference

Wednesday 15 May,2013

Puma Biotechnology to Present at UBS Global Healthcare Conference

Wednesday 15 May,2013

ABMC Reports First Quarter 2013 Results

Wednesday 15 May,2013

PharMerica to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Wednesday 15 May,2013

Research and Markets: Custirsen Sodium (Prostate Cancer) - Forecast and Market Analysis to 2022

Wednesday 15 May,2013

Research and Markets: PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022

Wednesday 15 May,2013

Gilead Sciences to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on Wednesday, May 15

Wednesday 15 May,2013

Research and Markets: Anemia Partnering 2007-2013 Contains Over 50 Links to Online Copies of Actual Anemia Deals and Contract Documents

Wednesday 15 May,2013

Research and Markets: Anxiety Partnering 2007-2013 Report Contains Over 35 Links to Online Copies of Actual Anxiety Deals and Contract Documents

Wednesday 15 May,2013

Research and Markets: Genitourinary Symptoms Partnering 2007-2013

Wednesday 15 May,2013

Research and Markets: Disease and Therapy Review 2012: Kidney Transplant

Wednesday 15 May,2013

Research and Markets: Multiple Sclerosis Partnering 2007-2013 Out Now

Wednesday 15 May,2013

Research and Markets: Disease and Therapy Review 2013: Stroke Study Provides a Concise Analysis of the Most Important Information

Wednesday 15 May,2013

Research and Markets: Psoriasis Partnering 2007-2013 Report is Essential Reading for those inside the Dermatology Field

Wednesday 15 May,2013

Research and Markets: Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q1 2013

Wednesday 15 May,2013

Research and Markets: Sepsis Partnering 2007-2013 Report Contains Over 30 Links to Online Copies of Actual Sepsis Deals and Contract Documents

Wednesday 15 May,2013

Research and Markets: Rebif (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wednesday 15 May,2013

Teva to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Wednesday 15 May,2013

Research and Markets: Idiopathic Pulmonary Fibrosis (IPF) - IPF Market to Hit $1 Billion in 2017 - Opportunities For Pharma Companies Willing to Research

Wednesday 15 May,2013

Research and Markets: NU-100 (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wednesday 15 May,2013

Research and Markets: Masitinib (Multiple Sclerosis) - Forecast and Market Analysis to 2022

Wednesday 15 May,2013

Research and Markets: Keeping up to Date as a (GMP) Qualified Person - A One Day Continuing Professional Development (CPD) (Workshop, London)

Wednesday 15 May,2013

Certara and Veristat Expand Clinical Trial Service Offerings with New Partnership

Wednesday 15 May,2013

Research and Markets: Roche Partnering 2005-2013 - Partnering Activities over the Past 7 Years

Wednesday 15 May,2013

Research and Markets: Hepatitis Partnering 2007-2013

Wednesday 15 May,2013

Research and Markets: Sleep disorders Partnering 2007-2013 - Access to Partnering Deals and Agreements

Wednesday 15 May,2013

Research and Markets: Blood Substitute Partnering 2007-2013 - Discover Partnering Trends

Wednesday 15 May,2013

Research and Markets: Huntingtons Disease Partnering 2007-2013 - Discover the Trends in Huntingtons Disease Partnering

Wednesday 15 May,2013

Merck to Present at the Bank of America/Merrill Lynch 2013 Healthcare Conference

Wednesday 15 May,2013

Research and Markets: Wrinkles Partnering 2007-2013 - Access to Deals Entered by Worlds Leading Healthcare Companies

Wednesday 15 May,2013

Alliance for Cancer Gene Therapy to Host Inaugural Foundation Symposium at the 16th Annual American Society of Gene and Cell Therapy Meeting

Wednesday 15 May,2013

Research and Markets: Therapeutic Drug Monitoring - Technologies, Markets, and Companies - Updated 2013 Report

Wednesday 15 May,2013

Simulations Plus Software Used in Regulatory Submittals

Wednesday 15 May,2013

Senesco Announces Presentation on Combination Therapy with Novel Nanoparticle, SNS01-T, and Bortezomib Results in Synergistic Cytotoxicity In Vitro and In Vivo in Multiple Myeloma

Wednesday 15 May,2013

AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease

Wednesday 15 May,2013

Ligand Partner Rib-X Initiates Phase 3 Trial of Captisol-enabled™ Delafloxacin IV

Wednesday 15 May,2013

Top Health Insurance Plans Expanded Coverage of the Verifi® Non-Invasive Prenatal Test to Detect Down Syndrome & Other Chromosomal Abnormalities

Wednesday 15 May,2013

Seattle Genetics Announces ADCETRIS® (Brentuximab Vedotin) Supplemental BLA Accepted for Filing by the FDA

Wednesday 15 May,2013

Vince and Associates Clinical Research Joins the Altasciences Group

Wednesday 15 May,2013

Ironwood and Forest to Present Linaclotide Data at Digestive Disease Week® 2013

Wednesday 15 May,2013

Neumedicines Receives BARDA Notification of Intent to Exercise Contract Option to Continue Development of HemaMax as Radiation Medical Countermeasure

Wednesday 15 May,2013

Rib-X Pharmaceuticals Initiates Delafloxacin Global Phase 3 Clinical Trial in Patients with Acute Bacterial Skin and Skin Structure Infections

Wednesday 15 May,2013

Third Rock Ventures Expands and Strengthens Team

Wednesday 15 May,2013

Bend Research Expands Analytical Sciences Capabilities and Capacity for Pharmaceutical Development

Wednesday 15 May,2013

Entera Health, Inc. Announces Presentations at Digestive Disease Week 2013

Wednesday 15 May,2013

Infinity to Present at the UBS Global Healthcare Conference

Wednesday 15 May,2013

Dr. Reddy’s Q4 & FY13 Financial Results

Tuesday 14 May,2013

Research and Markets: Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors

Tuesday 14 May,2013

Research and Markets: Competitor Analysis: Interferon

Tuesday 14 May,2013

NTRR Enters Final Stages of Negotiations With M&A Target

Tuesday 14 May,2013

Derma Sciences Engages Plexus Ventures to Explore Strategic Options for DSC127 Outside the U.S.

Tuesday 14 May,2013

Aradigm Announces First Quarter 2013 Financial Results

Tuesday 14 May,2013

Jack Green Joins Verastem as Chief Financial Officer

Tuesday 14 May,2013

Dr. Reddy’s Q4 & FY13 Financial Results

Tuesday 14 May,2013

Research and Markets: Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors

Tuesday 14 May,2013

Research and Markets: Competitor Analysis: Interferon

Tuesday 14 May,2013

NTRR Enters Final Stages of Negotiations With M&A Target

Tuesday 14 May,2013

Research and Markets: Brain Cancer Partnering 2007-2013 Provides the Reader with an In-Depth Understanding and Access to Brain Cancer Trends and Structure of Deals

Tuesday 14 May,2013

Research and Markets: Bladder Cancer Partnering 2007-2013 Contains Over 25 Links to Online Copies of Actual Bladder Cancer Deals

Tuesday 14 May,2013

Research and Markets: Chronic Kidney Disease Partnering 2007-2013 Study Available Now for Analysis

Tuesday 14 May,2013

Research and Markets: Bone Fracture Partnering 2007-2013 Available Now for Review

Tuesday 14 May,2013

Tetraphase Reports First Quarter 2013 Financial Results

Tuesday 14 May,2013

PerkinElmer to Present at UBS Global Healthcare Conference

Tuesday 14 May,2013

Covidien Announces Pricing of $750 Million Senior Notes Offering

Tuesday 14 May,2013

Research and Markets: Bipolar Disorder Partnering 2007-2013 Contains Over 20 Links to Online Copies of Actual Bipolar Disorder Deals and Contract Documents

Tuesday 14 May,2013

pSivida Corp. Reports Third Quarter Fiscal Year 2013 Results

Tuesday 14 May,2013

RegeneRx Issues Letter to Sharholders

Tuesday 14 May,2013

Research and Markets: Generic and Innovative Drugs Market in CIS Countries 2013 - Russia, Ukraine and Kazakhstan

Tuesday 14 May,2013

New clinical trial investigates APOKYN for treating debilitating morning akinesia in Parkinson’s disease patients

Tuesday 14 May,2013

Research and Markets: Bristol-Myers Squibb Partnering 2005-2013

Tuesday 14 May,2013

BioAlliance Pharma announces DSMB second positive recommendation to continue its Phase III clinical trial with Livatag® in primary liver cancer

Tuesday 14 May,2013

Research and Markets: Eli Lilly Partnering 2005-2013 - Understand Eli Lilly and Its Partnering Interests and Activities

Tuesday 14 May,2013

Bay City Capital Expands Team With the Addition of David Beier, JD

Tuesday 14 May,2013

Speaker Program Teams Are More Effective Than 3 to 5 Years Ago

Tuesday 14 May,2013

Piramal Enterprises Limited receives IND approval from the US FDA for its GPR40 agonist P11187; an anti-diabetic molecule

Tuesday 14 May,2013

U.S. Department of Veterans Affairs Chooses ViaValve™ Safety IV Catheter for Raymond G. Murphy VA Medical Center, Albuquerque

Monday 13 May,2013

Covidien Announces Senior Notes Offering

Monday 13 May,2013

Instem Enters Early Phase Clinical Market; Acquires Logos Technologies and ALPHADAS

Monday 13 May,2013

Medivir: U.S. FDA grants priority review to Simeprevir for combination treatment of genotype 1 chronic hepatitis C

Monday 13 May,2013

Research and Markets: Atherosclerosis Partnering Deals and Agreements 2007-2013

Monday 13 May,2013

Research and Markets: Academic/Non-Profit Partnering Yearbook 2013

Monday 13 May,2013

Research and Markets: Genitourinary Partnering Yearbook 2013 - The Latest Partnering Deals and Agreements

Monday 13 May,2013

Research and Markets: Pediatrics Partnering Yearbook 2013

Monday 13 May,2013

Pfizer Announces 11 Abstracts for Tofacitinib to Be Presented at the European League Against Rheumatism (EULAR) 2013 Annual Meeting

Monday 13 May,2013

Research and Markets: Arrhythmia Partnering Deals and Agreement 2007-2013

Monday 13 May,2013

BioTime’s Subsidiary Cell Cure Neurosciences Ltd. Awarded $1.5 Million Grant from Israel’s Office of the Chief Scientist

Monday 13 May,2013

NanoViricides, Inc. Brings in Experienced Executive as Interim CFO

Monday 13 May,2013

Walgreens Extends CVS Caremark Network Provider Agreement

Monday 13 May,2013

Rib-X Pharmaceuticals Appoints John E. Sununu to the Board of Directors

Monday 13 May,2013

Dyax Announces $30 Million Offering

Monday 13 May,2013

FDA Accepts Biogen Idec’s Biologics License Application for First Long-Lasting Factor VIII Therapy for Hemophilia A

Monday 13 May,2013

Mirna Therapeutics is First to Advance MicroRNA into the Clinic for Cancer

Monday 13 May,2013

AmerisourceBergen Completes Divestiture of AndersonBrecon

Monday 13 May,2013

EMD Millipore Receives Chairman’s Award from Massachusetts Governor at Associated Industries of Massachusetts Luncheon

Monday 13 May,2013

Relypsa Completes Patient Enrollment in Pivotal Phase 3 Program for the Treatment of Hyperkalemia

Monday 13 May,2013

Arrowhead to Present at Upcoming Scientific Conferences

Monday 13 May,2013

Spectrum Pharmaceuticals to Present Corporate Update at the UBS Global Healthcare Conference in New York City on May 20th

Monday 13 May,2013

Sucampo Pharmaceuticals to Host Update on AMITIZA® OIC Indication May 20th

Monday 13 May,2013

Cardinal Health Selects Hortonworks to Power Next-generation Data Platform for Healthcare

Monday 13 May,2013

ARIAD to Present at UBS Global Healthcare Conference

Monday 13 May,2013

Use of TYRX Antibacterial Envelope Associated with Extremely Low 90-Day Cardiac Device Infection Rates

Monday 13 May,2013

Research and Markets: Pharmaceutical Market India: A Comprehensive Industry Analysis

Monday 13 May,2013

Research and Markets: Healthcare, Regulatory and Reimbursement Landscape - Argentina

Monday 13 May,2013

Provectus Updates Shareholders in Its Annual CEO Letter

Monday 13 May,2013

Elan Provides Additional Commentary on Elan/Theravance Royalty Participation Agreement

Monday 13 May,2013

BioTime Announces First Quarter 2013 Financial Results and Recent Corporate Accomplishments

Monday 13 May,2013

Research and Markets: Cancer Vaccine Partnering Agreements - 2013 Gives Access to 150 Cancer Vaccine Deals

Monday 13 May,2013

Research and Markets: Central Nervous System Partnering Terms and Agreements - 2013 Report Features Players such as Bayer and Johnson & Johnson

Monday 13 May,2013

Research and Markets: Hematology Partnering Terms and Agreements - 2013 Features Players such as Lundbeck, GlaxoSmithKline and Astellas

Monday 13 May,2013

Research and Markets: Bacterial Partnering Terms and Agreements - 2013 Report Features Over 1,000 Links to Online Copies of Actual Bacterial Deals

Monday 13 May,2013

Research and Markets: Herpes simplex Partnering 2007-2013 Report Contains Links to Companies in the Field

Monday 13 May,2013

Research and Markets: Dental Partnering Terms and Agreements - 2013 Contains Over 500 Links to Online Copies of Actual Dental Deals

Monday 13 May,2013

Research and Markets: Cancer Monoclonal Antibody Partnering Terms and Agreements - 2013 Report Covers Over 1,000 Cancer Monoclonal Antibody Deals

Monday 13 May,2013

Research and Markets: Pediatrics Partnering Terms and Agreements - 2013 Report Features Players such as AstraZeneca, Biogen Idec and Merck & Co

Monday 13 May,2013

Research and Markets: Neuralgia Partnering 2007-2013 Report Provides the Reader With An In-Depth Understanding And Access To Neuralgia Trends And Structure Of Deals

Monday 13 May,2013

Oxygen Biotherapeutics Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th

Monday 13 May,2013

Research and Markets: The Corporate Reputation of Pharma in 2012: The Patient Perspective on 29 of the Worlds Leading Pharma Companies

Monday 13 May,2013

Research and Markets: Drug Addiction Partnering 2007-2013

Monday 13 May,2013

Quintiles Celebrates IPO on the New York Stock Exchange

Monday 13 May,2013

CEL-SCI Corporation Reports Second Quarter 2013 Financial Results

Monday 13 May,2013

MGH Institute of Health Professions Graduates Largest Class

Monday 13 May,2013

Impax Laboratories to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Monday 13 May,2013

Santarus Announces Pricing of Secondary Common Stock Offering by a Selling Stockholder

Monday 13 May,2013

Cancer Genetics Announces Conference Call to Discuss First Quarter Results

Monday 13 May,2013

Research and Markets: Neuromodulation Market Research Report Forecasts to 2017 - Neuromodulation emerging as one of the fastest growing segments of the medical device market

Monday 13 May,2013

A.P. Pharma Announces First Quarter 2013 Financial Results and Highlights Recent Corporate Progress

Monday 13 May,2013

Pernix Therapeutics Reports First Quarter 2013 Financial Results

Monday 13 May,2013

Acceleron’s ACE-536 Preclinical Data Presentation Selected for Best Abstract at 12th International Symposium on Myelodysplastic Syndromes

Monday 13 May,2013

Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas on May 14th

Monday 13 May,2013

BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results

Monday 13 May,2013

Company Profile for Izun Pharmaceuticals Corporation

Monday 13 May,2013

Zalicus Presents Data on Novel, Oral, N- and T-Type Calcium Channel Blockers for the Treatment of Pain

Monday 13 May,2013

Spectrum Pharmaceuticals to Present Corporate Update at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas on May 14th

Friday 10 May,2013

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

Friday 10 May,2013

New World-First Technology Use at Saskatchewan Disease Control Laboratory

Friday 10 May,2013

InSite Vision Initiates Confirmatory Phase 3 Clinical Study of BromSite™ for the Reduction of Inflammation and Pain after Cataract Surgery

Friday 10 May,2013

Walgreens to Present at Bank of America Merrill Lynch 2013 Health Care Conference May 16

Friday 10 May,2013

Santarus Announces Launch of a Proposed Secondary Common Stock Offering by a Selling Stockholder

Friday 10 May,2013

Salix Pharmaceuticals Reports 1Q2013 Results

Friday 10 May,2013

Anacor Pharmaceuticals Reports First Quarter 2013 Financial Results

Friday 10 May,2013

Saskatchewan Disease Control Laboratory Selects Fluidigm BioMarkTM HD Platform to Track Infectious Agents

Friday 10 May,2013

Arrowhead Reports Fiscal 2013 Second Quarter Financial Results

Friday 10 May,2013

Research and Markets: Stability Testing of Pharmaceuticals and Biopharmaceuticals - Including Practical Workshops (Conference, London) - 2013

Friday 10 May,2013

At HRS GE Healthcare Showcases Integrated Visualization Technology with Increased Versatility and More Effective Dose Management

Friday 10 May,2013

Research and Markets: Gynecology Partnering Terms and Agreements - 2013 Study Contains Over 500 Links to Online Copies of Actual Gynecology Deals and Contract Documents

Friday 10 May,2013

New Catheter from Dolor Technologies Used by Physicians Who Treat Chronic Headache and Other Disorders

Friday 10 May,2013

A Clinical Study Shows the Theracurmin®’s Safety and Potential Role in Improving Quality of Life (QOL) of Pancreatic Cancer Patients

Friday 10 May,2013

MannKind Corporation Reports 2013 First Quarter Financial Results

Friday 10 May,2013

Bayer Airship Serves as 150th Anniversary Ambassador

Friday 10 May,2013

With Doping Cloud Lifted, BuckPower Deer Antler Velvet Sales up 84% at GNC Retail Stores

Friday 10 May,2013

Research and Markets: Viral Partnering Terms and Agreements - 2013 Report Features Players such as AstraZeneca and Novartis

Friday 10 May,2013

Research and Markets: Pfizer Partnering 2005-2013 - Insights into Terms Included in Pfizers Partnering Agreements

Friday 10 May,2013

Research and Markets: Advanced EU Pharmaceutical Regulatory Affairs - To Help you Improve and Optimise your Drug Submission Procedures (Conference, London)

Friday 10 May,2013

Research and Markets: Novo Nordisk Partnering 2005-2013

Friday 10 May,2013

Research and Markets: Valeant Partnering 2005-2013 - Access to Partnering Activities over the past 7 Years

Friday 10 May,2013

Research and Markets: Pharmacy Retail Market in India 2013

Friday 10 May,2013

BioCryst to Present at Two Upcoming Investor Conferences

Friday 10 May,2013

ISR’s Risk-based Monitoring Report Offers Industry Peer-based Guidance

Friday 10 May,2013

Izun Pharmaceuticals Initiates Additional Oral Mucositis Trial Sites

Friday 10 May,2013

Onconova Completes Enrollment in ONTIME Pivotal Phase 3 Study of Rigosertib in Patients with High-risk Myelodysplastic Syndromes

Friday 10 May,2013

NPS Pharmaceuticals Reports First Quarter 2013 Financial Results

Friday 10 May,2013

ImmunoCellular Therapeutics Announces First Quarter 2013 Financial Results

Friday 10 May,2013

Dendreon Announces First Quarter 2013 Results

Friday 10 May,2013

Puma Biotechnology Reports First Quarter 2013 Financial Results

Friday 10 May,2013

Bioanalytical Systems to Release Second Quarter Results Wednesday, May 15, 2013; Conference Call & Webcast Set For 11:00 a.m. EDT

Friday 10 May,2013

IMS Health Study Points to a Declining Cost Curve for U.S. Medicines in 2012

Friday 10 May,2013

CytRx Reports 2013 First Quarter Financial Results

Friday 10 May,2013

Seattle Genetics to Present at Upcoming Investor Conferences

Friday 10 May,2013

Health Statistics Pioneer Dorothy P. Rice, Sc.D., Named 2013 Recipient of the William B. Graham Prize for Health Services Research

Friday 10 May,2013

Define Vendor Site Selection Strategy to Jump-Start Phase 1 Trials

Friday 10 May,2013

Research and Markets: Marketed Partnering Yearbook 2013

Thursday 9 May,2013

Research and Markets: Cell Therapy Partnering Yearbook 2013

Thursday 9 May,2013

InVivo Therapeutics Reports First Quarter 2013 Financial Results, Provides Business Update

Thursday 9 May,2013

Trevena Inc. and Forest Laboratories Announce a Collaborative Agreement for Development of TRV027 for the Treatment of Acute Heart Failure

Thursday 9 May,2013

Precision Therapeutics Presents Clinical Data Demonstrating Prediction for Platinum Resistance to First-Line Chemotherapy in Primary Ovarian Cancer at WAGO

Thursday 9 May,2013

Quintiles Announces Pricing of Initial Public Offering

Thursday 9 May,2013

Exelixis Announces Webcasts of Upcoming Investor Conference Presentations

Thursday 9 May,2013

AHF Shareholder Advocates Challenge Gilead on Drug Pricing at AGM

Thursday 9 May,2013

TherapeuticsMD Reports First Quarter 2013 Financial Results

Thursday 9 May,2013

Cubist to Present at Bank of America Merrill Lynch 2013 Healthcare Conference

Thursday 9 May,2013

Response to Planned Closure of Imaging Lab Good News Story of the Year

Thursday 9 May,2013

Acucela and Otsuka Pharmaceutical Announce Phase IIa Clinical Results of Emixustat Hydrochloride (ACU-4429) in Patients with Geographic Atrophy (GA) Associated with Dry Age-Related Macular Degeneration (AMD) at ARVO 2013 Annual Meeting

Thursday 9 May,2013

Research and Markets: Ovarian Cancer Partnering 2007-2013 Report Contains over 75 Links to Ovarian Cancer Deals

Thursday 9 May,2013

Research and Markets: Oral Health Partnering 2007-2013 Provides Everything a Prospective Dealmaker Needs to Know

Thursday 9 May,2013

Research and Markets: Migraine Partnering 2007-2013 Report provides the Reader with an in-depth understanding to migraine Trends and Structure of Deals

Thursday 9 May,2013

Research and Markets: Sexual Health Partnering Terms and Agreements - 2013

Thursday 9 May,2013

Research and Markets: Sun Damage Partnering 2007-2013 Report Provides an Analysis of Sun Damage Partnering Deals

Thursday 9 May,2013

Research and Markets: Respiratory Partnering Terms and Agreements - 2013

Thursday 9 May,2013

Ligand Reports First Quarter Financial Results

Thursday 9 May,2013

Research and Markets: Viral Partnering Terms and Agreements - 2013

Thursday 9 May,2013

Lannett Reports Record Fiscal 2013 Third Quarter Financial Results

Thursday 9 May,2013

Research and Markets: Gynecology Partnering Terms and Agreements - 2013 Report Features Players Pfizer, Bayer and Abbott

Thursday 9 May,2013

BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed Merger

Thursday 9 May,2013

Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference

Thursday 9 May,2013

Research and Markets: Dermatology Partnering Terms and Agreements - 2013

Thursday 9 May,2013

Second Annual BioNJ Diagnostics & Personalized Medicine Innovation Summit Taking Place at Sanofi

Thursday 9 May,2013

Research and Markets: Companion Diagnostics Partnering Terms & Agreements - 2013

Thursday 9 May,2013

Techulon Awarded $1.9M to Defeat “Superbugs”

Thursday 9 May,2013

Alnylam to Webcast Presentation at 2013 Bank of America Merrill Lynch Health Care Conference

Thursday 9 May,2013

Retrophin Names Marc L. Panoff as Chief Financial Officer

Thursday 9 May,2013

Research and Markets: Cell Culture Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018

Thursday 9 May,2013

Transgenomic Reports First Quarter 2013 Financial Results

Thursday 9 May,2013

Research and Markets: Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017

Thursday 9 May,2013

New Data Presented Demonstrates Ovulatory Effect of Teva Women’s Health’s Investigational 28-Day Oral Contraceptive

Thursday 9 May,2013

LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Thursday 9 May,2013

Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference

Thursday 9 May,2013

Reminder: Transgenomic to Hold First Quarter Financial Results Conference Call Today

Thursday 9 May,2013

Rite Aid to Celebrate Market-Wide Transformation of Stores in Buffalo

Thursday 9 May,2013

Selventa Strengthens Intellectual Property for System Diagnostics (SysDx™) Approach to Personalized Medicine

Thursday 9 May,2013

Enanta Pharmaceuticals Announces Financial Results for the Second Fiscal Quarter and Six Months Ended March 31, 2013

Thursday 9 May,2013

Teva and Alexza Announce Teva’s License to Market ADASUVE® in the U.S.

Thursday 9 May,2013

Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet

Thursday 9 May,2013

PerkinElmer Introduces New Chemical Intelligence Capabilities for Accelerating the Lead Discovery Process

Thursday 9 May,2013

Zalicus Secures New $25 Million Funding Commitment from Lincoln Park Capital

Thursday 9 May,2013

CytRx Provides Update on Clinical Programs

Thursday 9 May,2013

Alexion to Present at the BofA Merrill Lynch 2013 Healthcare Conference

Thursday 9 May,2013

Systech International and Tata Consultancy Services Partner to Deliver Scalable Serialization Solutions to the Life Sciences Industry

Thursday 9 May,2013

Thermo Fisher Scientific to Host Analyst Meeting

Thursday 9 May,2013

MannKind to Present at Bank of America Merrill Lynch 2013 Health Care Conference

Thursday 9 May,2013

Puma Biotechnology to Present at Bank of America Merrill Lynch 2013 Health Care Conference

Thursday 9 May,2013

Clovis Oncology to Present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas

Thursday 9 May,2013

Eleven Biotherapeutics Presents Data on EBI-005, a Novel IL-1 Inhibitor Protein Therapeutic for Topical Treatment of Dry Eye Disease

Thursday 9 May,2013

Research and Markets: Ion Channel Modulators - Global Strategic Business Report - 2013-2018

Wednesday 8 May,2013

Research and Markets: Digital Pathology Systems - Global Strategic Business Report - 2013-2018

Wednesday 8 May,2013

Research and Markets: Personalized Medicine - Scientific and Commercial Aspects - Updated 2013 Report

Wednesday 8 May,2013

Research and Markets: Ophthalmics Partnering Terms & Agreements

Wednesday 8 May,2013

Research and Markets: Sensory Organ Partnering Terms and Agreements

Wednesday 8 May,2013

Research and Markets: Gastrointestinal Partnering Terms and Agreements 2013: Latest Analysis from the Worlds Leadng Healthcare Companies

Wednesday 8 May,2013

Research and Markets: Partnerships, Licensing, Investments and M&A Deals and Trends for 03 - 2013 in Pharmaceuticals

Wednesday 8 May,2013

Cell Medica Announces Treatment of First Pediatric Patient in Early Stage Clinical Trial of Cytovir ADV

Wednesday 8 May,2013

Aviir Inc., Launches Complete Cardiovascular Genetic Testing

Wednesday 8 May,2013

Sydney Based Cellmid Acquires Japanese Advangen

Wednesday 8 May,2013

Elixir Medical Announces FDA Approval to Commence EXCELLA III Clinical Trial with DESyne® Nx Novolimus Eluting Coronary Stent System in the United States

Wednesday 8 May,2013

Idera Announces Presentation of Positive Data from Phase 2 Trial of TLR 7 and 9 Antagonist in Patients with Moderate-to-Severe Plaque Psoriasis

Wednesday 8 May,2013

Navidea Biopharmaceuticals Announces First Quarter 2013 Results

Wednesday 8 May,2013

First Databank Research on Use of Structured Product Labeling to Identify Prescription Drugs With Boxed Warnings Finds Numerous Inconsistencies

Wednesday 8 May,2013

Verastem to Present at Upcoming Conferences

Wednesday 8 May,2013

Antares Pharma Reports First Quarter 2013 Operating and Financial Results

Wednesday 8 May,2013

Pacira Pharmaceuticals, Inc. Reports $10.4 Million in First Quarter EXPAREL Revenue and Full First Quarter 2013 Financial Results

Wednesday 8 May,2013

Pacira Pharmaceuticals, Inc. to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Wednesday 8 May,2013

LabConnect Expands North American Headquarters in Seattle

Wednesday 8 May,2013

ArQule Reports First Quarter 2013 Financial Results

Wednesday 8 May,2013

Covidien and Mallinckrodt to Present at Bank of America Merrill Lynch Conference

Wednesday 8 May,2013

Walgreens Celebrates San Francisco Flagship Store Opening with Ribbon Cutting

Wednesday 8 May,2013

Astellas Awards Accenture Contract to Standardize Global IT Operations

Wednesday 8 May,2013

Research and Markets: Accident & Emergency Partnering 2007-2013 Contains Over 120 Links to Online Copies of Actual Accident & Emergency Deals

Wednesday 8 May,2013

Research and Markets: E.coli Partnering 2007-2013 Contains Over 30 Links to Online Copies of Actual E-Coli Deals and Contract Documents

Wednesday 8 May,2013

Research and Markets: Pharmacogenomics Partnering Terms and Agreements - 2013

Wednesday 8 May,2013

Research and Markets: Vaccine Partnering Terms and Agreements - 2013

Wednesday 8 May,2013

Research and Markets: Stroke Partnering 2007-2013 Report Contains Over 80 Links to Online Copies of Actual Stroke Deals and Contract Documents

Wednesday 8 May,2013

Research and Markets: Renal Failure Partnering 2007-2013 Provides the Reader with an In-Depth Understanding and Access to Renal Failure Trends and Structure of Deals by Leading Companies Worldwide

Wednesday 8 May,2013

Exelixis Announces First Quarter 2013 Financial Results

Wednesday 8 May,2013

Research and Markets: Companion Diagnostics Partnering Terms & Agreements - 2013

Wednesday 8 May,2013

pSivida Corp. Announces Commercial Launch of ILUVIEN® in Germany with First Patient Treated

Wednesday 8 May,2013

Cabozantinib to be Featured in Nine Presentations at the 2013 ASCO Annual Meeting

Wednesday 8 May,2013

Research and Markets: The Pharmaceutical Market: Malta 2013

Wednesday 8 May,2013

Idera Pharmaceuticals Announces Closing of Common Share Offering

Wednesday 8 May,2013

Research and Markets: Amgen Partnering 2005-2013

Wednesday 8 May,2013

Research and Markets: Conjunctivitis Partnering 2007-2013

Wednesday 8 May,2013

Sucampo Pharmaceuticals, Inc. Reports First Quarter 2013 Financial and Operating Results

Wednesday 8 May,2013

Anacor Pharmaceuticals Announces First Quarter 2013 Financial Results Conference Call and Webcast

Wednesday 8 May,2013

Furiex Reports First Quarter 2013 Financial Results

Wednesday 8 May,2013

Codexis Reports First Quarter 2013 Results

Wednesday 8 May,2013

Research and Markets: Actelion Partnering 2005-2013

Wednesday 8 May,2013

Research and Markets: Retinopathy Partnering 2007-2013

Wednesday 8 May,2013

Research and Markets: Glaucoma Partnering 2007-2013 - Access to Deals by Worlds Leading Healthcare Companies

Wednesday 8 May,2013

Research and Markets: Dry Eye Partnering 2007-2013 - Comprehensive access to over 30 actual dry eye deals entered into by the worlds biopharma companies since 2007

Wednesday 8 May,2013

Xcovery Vision Presents VEGFR/PDGFR Oral Inhibitor X-82 Preliminary Data for Wet AMD at ARVO

Wednesday 8 May,2013

Infinity Reports First Quarter 2013 Financial Results and Provides Company Update

Wednesday 8 May,2013

ACADIA Pharmaceuticals Reports First Quarter 2013 Financial Results

Wednesday 8 May,2013

AHF: Fed Court Throws Out California Pharmacy Cuts

Wednesday 8 May,2013

Lantheus Medical Imaging to Host First Quarter 2013 Conference Call on May 14, 2013 at 4:00 P.M. Eastern Time

Wednesday 8 May,2013

Seattle Genetics Reports First Quarter 2013 Financial Results

Wednesday 8 May,2013

Research and Markets: Pain Partnering 2007-2013: Partnering Deals and Agreements by the Worlds Leading Healthcare Companies

Wednesday 8 May,2013

Tennessee Physician Awarded Master of the American College of Endocrinology

Wednesday 8 May,2013

Iron Deficiency Anemia Pipeline Reviewed by Global Markets Direct in New Report Available at MarketPublishers.com

Wednesday 8 May,2013

AstraZeneca and Bristol–Myers Squibb Receive Award from Major Medical Association

Wednesday 8 May,2013

Japanese Pharmaceutical Industry Reviewed by GBI Research in In-Demand Study Now Available at MarketPublishers.com

Wednesday 8 May,2013

Research and Markets: Pain Therapeutics - Drugs, Markets and Companies - Updated 2013 Report

Wednesday 8 May,2013

Natural Relief for Eczema Available at Home from Jason International’s Oxygen Bath

Wednesday 8 May,2013

Walgreens Celebrates San Francisco Flagship Store Opening with Ribbon Cutting

Wednesday 8 May,2013

Walgreens to Debut San Francisco Flagship Store on May 8 at the Corner of Powell and O’Farrell

Wednesday 8 May,2013

Research and Markets: The Worldwide Guide to Pricing & Reimbursement

Wednesday 8 May,2013

Research and Markets: Partnerships, Licensing, Investments and M&A Deals and Trends for February 2013 in Pharmaceuticals

Wednesday 8 May,2013

Thermo Fisher Scientific to Present at the Bank of America Merrill Lynch 2013 Health Care Conference on May 14, 2013

Wednesday 8 May,2013

BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research

Wednesday 8 May,2013

Osiris Therapeutics Announces First Quarter 2013 Financial Results

Wednesday 8 May,2013

Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimers Disease

Wednesday 8 May,2013

Opsona Therapeutics Ltd. Initiates a Phase II Study with OPN-305, a First-in Class Monoclonal Antibody that Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function

Wednesday 8 May,2013

BioLineRx Reports First Quarter 2013 Results

Wednesday 8 May,2013

Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2013 Health Care Conference

Wednesday 8 May,2013

Prolacta Praises Landmark Legislation in Kentucky Mandating Human Milk Diet for Preemies in Jeopardy of Intestinal Disease

Wednesday 8 May,2013

Akorn Reports First Quarter 2013 Financial Results

Wednesday 8 May,2013

Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone

Wednesday 8 May,2013

Veeva Systems Introduces Complete, Cloud-Based Customer Master Solution for Life Sciences Companies

Wednesday 8 May,2013

OncoSec Medical to Present at the Sachs Cancer Bio Partnering Forum and Participate in a Panel Discussion on Immunotherapies and Cancer Vaccines

Wednesday 8 May,2013

ARIAD Reports First Quarter 2013 Financial Results and Development Progress

Wednesday 8 May,2013

FDA Grants Fast Track Designation for Cubist’s Late-Stage Antibiotic Candidate

Wednesday 8 May,2013

InSite Vision Reports First Quarter 2013 Financial Results

Wednesday 8 May,2013

Digestive Health of Many American Women Not Making the Grade

Wednesday 8 May,2013

Clovis Oncology Announces First Quarter 2013 Operating Results

Wednesday 8 May,2013

Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial

Wednesday 8 May,2013

BioCryst Provides Corporate Update and Reports First Quarter 2013 Financial Results

Wednesday 8 May,2013

Enzo and NIH File Patent Application for Therapies, Diagnosis, and Prognosis for Autoimmune Diseases

Wednesday 8 May,2013

Prescription Drug Costs Among Top Concerns for Medicare Beneficiaries; More Than 20 Percent Report Skipping Doses or Postponing Medication Refills

Wednesday 8 May,2013

Aeras, Oxford University, Okairos: TB, HIV and Malaria Vaccine Research Gets Major Boost

Wednesday 8 May,2013

Medidata Solutions Appoints Steven Wilhite as Chief Marketing Officer

Wednesday 8 May,2013

Aptiv Solutions to Deliver Keynote at University of Tokyo Conference on Adaptive Clinical Trials

Wednesday 8 May,2013

Salix Pharmaceuticals to Present at BofA Merrill Lynch 2013 Health Care Conference

Wednesday 8 May,2013

Armada Health Care Chooses BusinessOne Technologies to Optimize Access, Distribution and Reimbursement Activities

Wednesday 8 May,2013

Connie Wierman is New Theorem Vice President of Biopharmaceutical Development

Wednesday 8 May,2013

BIO to Use ViS Analytics to Streamline Pediatric Clinical Research

Wednesday 8 May,2013

Liaison Healthcare Launches Global CRO Integration Hub for Real-time Access to Clinical Trial Information

Wednesday 8 May,2013

Synageva BioPharma™ Reports First Quarter 2013 Financial Results

Wednesday 8 May,2013

Bond Labs Strengthens its Credit Facility

Wednesday 8 May,2013

Osiris Therapeutics Announces First Quarter 2013 Financial Results

Tuesday 7 May,2013

Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimers Disease

Tuesday 7 May,2013

Opsona Therapeutics Ltd. Initiates a Phase II Study with OPN-305, a First-in Class Monoclonal Antibody that Blocks Toll-Like Receptor 2, in Renal Transplant Patients at High Risk of Delayed Graft Function

Tuesday 7 May,2013

BioLineRx Reports First Quarter 2013 Results

Tuesday 7 May,2013

Akorn Reports First Quarter 2013 Financial Results

Tuesday 7 May,2013

Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone

Tuesday 7 May,2013

OncoSec Medical to Present at the Sachs Cancer Bio Partnering Forum and Participate in a Panel Discussion on Immunotherapies and Cancer Vaccines

Tuesday 7 May,2013

ARIAD Reports First Quarter 2013 Financial Results and Development Progress

Tuesday 7 May,2013

FDA Grants Fast Track Designation for Cubist’s Late-Stage Antibiotic Candidate

Tuesday 7 May,2013

Digestive Health of Many American Women Not Making the Grade

Tuesday 7 May,2013

Clovis Oncology Announces First Quarter 2013 Operating Results

Tuesday 7 May,2013

Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial

Tuesday 7 May,2013

BioCryst Provides Corporate Update and Reports First Quarter 2013 Financial Results

Tuesday 7 May,2013

Enzo and NIH File Patent Application for Therapies, Diagnosis, and Prognosis for Autoimmune Diseases

Tuesday 7 May,2013

Aeras, Oxford University, Okairos: TB, HIV and Malaria Vaccine Research Gets Major Boost

Tuesday 7 May,2013

Medidata Solutions Appoints Steven Wilhite as Chief Marketing Officer

Tuesday 7 May,2013

Aptiv Solutions to Deliver Keynote at University of Tokyo Conference on Adaptive Clinical Trials

Tuesday 7 May,2013

Salix Pharmaceuticals to Present at BofA Merrill Lynch 2013 Health Care Conference

Tuesday 7 May,2013

Connie Wierman is New Theorem Vice President of Biopharmaceutical Development

Tuesday 7 May,2013

San Diego Physician Installed as President of the American College of Endocrinology

Tuesday 7 May,2013

Dallas Based Physician Elected Secretary of Major Physician Organization

Tuesday 7 May,2013

Illinois Based Physician Elected Treasurer of Major Physician Organization

Tuesday 7 May,2013

Baxter Raises Dividend Nine Percent

Tuesday 7 May,2013

Michigan Based Physician Elected Vice President of Major Physician Organization

Tuesday 7 May,2013

pSivida Corp. Announces Third Quarter 2013 Financial Results Release Date and Conference Call Information

Tuesday 7 May,2013

Florida Physician Becomes President Elect of Major Physician Organization

Tuesday 7 May,2013

New York Based Physician Elected President of Major Physician Organization

Tuesday 7 May,2013

Charles River Laboratories to Present at Baird’s Growth Stock Conference

Tuesday 7 May,2013

Walgreens Announces Alliance Boots to Release Year-End Results on May 15

Tuesday 7 May,2013

Alnylam Pharmaceuticals Reports First Quarter 2013 Financial Results

Tuesday 7 May,2013

Santarus Reports First Quarter 2013 Financial Results

Tuesday 7 May,2013

New York Parents Charge Pfizer Actively Concealed True Risks Of Birth Defects To Infants From Zoloft When Prescribed To Mothers During Pregnancy

Tuesday 7 May,2013

ARCA Announces Death of Board Member Burton E. Sobel, Preeminent Physician Scientist and Academic Leader

Tuesday 7 May,2013

Two New Studies Support Use of EXPAREL via Infiltration Into the Transversus Abdominis Plane for Postsurgical Pain Control

Tuesday 7 May,2013

Etubics Platform Generates Solid Immune Response in Colorectal Cancer Patients

Tuesday 7 May,2013

Bristol-Myers Squibb and Pfizer Announce Publication of ARISTOTLE Subanalysis in Circulation

Tuesday 7 May,2013

Teva Women’s Health to Present New Data at the 61st Annual Meeting of the American Congress of Obstetricians and Gynecologists

Tuesday 7 May,2013

Triumph Over Superbugs Will Only Come from C-Suite-Supported Multimodal Intervention, Says Environmental Hygiene Advocate

Tuesday 7 May,2013

AmerisourceBergen Approves Quarterly Dividend

Tuesday 7 May,2013

Breakthrough Therapy Designation from the U.S. Food and Drug Administration Granted to Investigational HCV Regimen Containing Protease Inhibitor ABT-450

Tuesday 7 May,2013

Covidien Appoints Jacqueline Strayer Senior Vice President, Corporate Communications

Tuesday 7 May,2013

The Patient Recruiting AgencyTM Announces a Medical Research Study for Individuals with Thyroid Eye Disease (Also Called Graves’ Orbitopathy)

Tuesday 7 May,2013

44% of Pharma Companies Wait Until It’s Too Late to Implement Counter-Generics Strategies

Tuesday 7 May,2013

AltheRx Presents Data on Improved Efficacy in an Experimental Combination of Beta3-Adrenoceptor Agonists and Antimuscarinics at AUA Annual Meeting

Tuesday 7 May,2013

Ajinomoto’s North Carolina Plant Receives ISO 9001 Certification

Tuesday 7 May,2013

Ignyta and UC San Diego Researchers Find that Permanent Epigenetic Alterations Are Associated with Immune Function in Rheumatoid Arthritis

Tuesday 7 May,2013

Onset Dermatologics Launches Patented Aurstat® Anti-Itch Hydrogel 225mL

Tuesday 7 May,2013

Bio-IT World & Molecular Medicine Tri-Conference Asia Two Events in Singapore. One Location. May 28-31, 2013

Tuesday 7 May,2013

CEL-SCI Presents Data Showing LEAPS Vaccine is Successful in Reducing Rheumatoid Arthritis Index Score in a Second Animal Model

Monday 6 May,2013

Senesco Announces Start of Cohort 3 in Phase 1b/2a Study in Multiple Myeloma and Non-Hodgkins B-Cell Lymphoma

Monday 6 May,2013

Six-Month Results Show DKT Pakistan as Latest Social Impact Success

Monday 6 May,2013

Medidata Solutions to Present at the Jefferies 2013 Global Technology, Media & Telecom Conference

Monday 6 May,2013

Introducing BestCo: New Name, Logo Reflect Growth and Evolution of BestSweet

Monday 6 May,2013

CytRx Receives Recommendation from Data Safety Monitoring Committee to Complete International Phase 2b Trial with Aldoxorubicin as First-Line Treatment for Soft Tissue Sarcoma

Monday 6 May,2013

Cook Medical Launches Flexor® Vue™ Deflecting Endoscopic System

Monday 6 May,2013

BIND Therapeutics to Present at the UBS Global Healthcare Conference

Monday 6 May,2013

Facing Off Against Counterfeit Online Pharmacies: Pfizer Launches New Purchasing Website To Help Alleviate the Guesswork Around Buying Legitimate Viagra® (sildenafil citrate) Online

Monday 6 May,2013

Kala Presents Data on Enhanced Topical Ocular Delivery of a Receptor Tyrosine Kinase Inhibitor

Monday 6 May,2013

Health Net Stresses Importance of Preconception Health

Monday 6 May,2013

Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period

Monday 6 May,2013

Concert Pharmaceuticals Announces Strategic Collaboration with Celgene Corporation to Develop Deuterium-Modified Compounds

Monday 6 May,2013

Collaboration Between SwedenBIO and partneringONE® by EBD Group to Facilitate Partnering at Nordic Life Science Days 2013

Monday 6 May,2013

Acorda Therapeutics Recognized as One of the Best Places to Work in New York State for Third Consecutive Year

Monday 6 May,2013

Transgenomic Signs Collaboration Agreement with Amgen for Development of CE-IVD CRC RAScan™ Mutation Detection Tests for Patients with Metastatic Colorectal Cancer

Monday 6 May,2013

FzioMed Receives Approval for Dynavisc® in Australia

Monday 6 May,2013

Men: Sometimes it’s Not Her, it’s YOU

Monday 6 May,2013

DVS Sciences Introduces the CyTOF® 2 Mass Cytometer and New MaxPar® Panel Kits for Transformational High-Parameter Single Cell Analysis

Monday 6 May,2013

Using Sweat to Detect Diabetic Neuropathy

Monday 6 May,2013

Christiana Care Health System features world-renowned Infectious Disease experts at 50th anniversary symposium

Monday 6 May,2013

Study Underscores Importance of Physical Exams As Diagnostic Tool for Thyroid Cancer

Monday 6 May,2013

Cause and Effect: Case Report Shows an Association between Sugar Substitutes and Common Thyroid Disorder

Monday 6 May,2013

6.5 Million Jury Verdict in First Actos Trial Vacated by Court

Monday 6 May,2013

The Miller Firm helps cancer victim obtain $6.5 million verdict against diabetes drug maker

Monday 6 May,2013

U.S.-Israel Business Exchange to Be Held in Charleston Next Week

Monday 6 May,2013

Covidien Announces First Full-Year Outlook for Mallinckrodt plc

Monday 6 May,2013

FDA Approves Merck’s LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol

Monday 6 May,2013

XenoPort Announces New Employment Inducement Awards

Monday 6 May,2013

Covidien Announces 2013 Guidance and Provides Historical Financial Statements Adjusted for Discontinued Operations

Monday 6 May,2013

Research and Markets: Top Five Global Cardiovascular Drug Companies 2013 Report Features Players such as Pfizer and AstraZeneca

Monday 6 May,2013

Research and Markets: The Global Pharmaceutical Industry Is Expected To Reach $1,241 Billion By 2016, Growing At A CAGR Of 5.7%.

Monday 6 May,2013

Navidea Biopharmaceuticals to Announce First Quarter 2013 Financial Results Pre-market on Wednesday, May 8, 2013

Monday 6 May,2013

Pernix Therapeutics to Report First Quarter 2013 Financial Results on May 10, 2013

Monday 6 May,2013

Exact Sciences to Participate in May Investor Conferences

Monday 6 May,2013

HHS Secretary Kathleen Sebelius on Older Americans Month

Monday 6 May,2013

iCAD’s Xoft Intraoperative Radiation Therapy System Featured at American Society of Breast Surgeons Conference

Monday 6 May,2013

Research and Markets: Johnson & Johnson / Janssen Partnering 2005-2013

Friday 3 May,2013

Research and Markets: Rehabilitation Medicine Partnering 2007-2013

Friday 3 May,2013

Research and Markets: Sexually Transmitted Diseases Partnering 2007-2013

Friday 3 May,2013

Research and Markets: Sexual Dysfunction Partnering 2007-2013 - Access to Partnering Deals by the Worlds Leading Healthcare Companies

Friday 3 May,2013

Research and Markets: 2013 Global HIV/AIDS Diagnostics Market: Growth Opportunities and Business Expansion Strategies

Friday 3 May,2013

Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA® (efavirenz) in HIV-1 Infected Pediatric Patients

Friday 3 May,2013

Walgreens April Sales Increase 3.8 Percent

Friday 3 May,2013

Maxygen Reports First Quarter 2013 Financial Results

Friday 3 May,2013

SQI Announces Closing of Private Placement

Friday 3 May,2013

Incyte to Present at Upcoming Investor Conferences

Friday 3 May,2013

InVivo Therapeutics Announces Call Notice for Exercise of Warrants and Partial Termination of Warrant Exchange Offer

Friday 3 May,2013

GTx Provides Corporate Update and Reports First Quarter 2013 Financial Results

Friday 3 May,2013

ImmunoGen, Inc. Announces Webcast of Presentation at Upcoming Investor Conference

Friday 3 May,2013

Anacor Pharmaceuticals Provides Update Regarding Arbitration With Valeant Pharmaceuticals

Friday 3 May,2013

Fewer Needle Pricks for Thyroid Biopsies

Friday 3 May,2013

Research and Markets: Inhalation & Nasal Spray Generic Drugs 2012

Friday 3 May,2013

Research and Markets: The Complete Guide to Companion Diagnostics: Market Environment Products and Companies

Friday 3 May,2013

When Fat Is Good: Brown Adipose Tissue (BAT) Shows Potential As Obesity Buster

Friday 3 May,2013

AHF Says Corporate Welfare Fuels Gilead’s Record Q1 Profits

Friday 3 May,2013

FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face

Friday 3 May,2013

BIO Shares U.S. Trade Representatives International Patent Concerns

Friday 3 May,2013

CORRECTING and REPLACING Esperion Therapeutics Presents Full Results of Phase 2 Clinical Trial Showing Its Novel Oral Therapy ETC-1002 Lowered LDL-C By Up to 43 Percent in Hypercholesterolemic Patients with Type 2 Diabetes

Friday 3 May,2013

Esperion Therapeutics Presents Full Results of Phase 2 Clinical Trial Showing Its Novel Oral Therapy ETC-1002 Lowered LDL-C By Up to 43 Percent in Hypercholesterolemic Patients with Type 2 Diabetes

Friday 3 May,2013

Gilead Sciences Announces First Quarter 2013 Financial Results

Friday 3 May,2013

Emergent BioSolutions Reports Financial Results for First Quarter 2013

Friday 3 May,2013

Research and Markets: Post Menopausal Osteoporosis - Pipeline Review, H1 2013

Friday 3 May,2013

AVEO and Astellas Report FDA Oncologic Drug Advisory Committee Votes Tivozanib Application Did Not Demonstrate Favorable Benefit-to-Risk Evaluation in Treatment of Advanced Renal Cell Carcinoma

Friday 3 May,2013

BioLineRxs BL-7010, for the Treatment of Celiac, to be Presented at Two Leading Conferences

Friday 3 May,2013

New Initiative to Improve Medication Adherence Unveiled By Health Care, Consumer, Patient and Industry Leaders

Friday 3 May,2013

Alliance Life Sciences Releases White Paper: Global Business Planning for Competitive Growth in Emerging Markets Enhances Strategic Opportunities

Friday 3 May,2013

CRI Lifetree to Share Pain Research Expertise at the American Pain Society’s Annual Scientific Meeting

Friday 3 May,2013

Oragenics Launches New Professional and Consumer Commercial Websites

Friday 3 May,2013

AltheRx Pharmaceuticals Raises $15 Million, Names Jim Bennethum Chief Executive Officer and Appoints a New Board of Directors

Friday 3 May,2013

New Clinical Guideline Affirms Pre-Seed as “Sperm Safe” Lubricant

Friday 3 May,2013

Thermo Fisher Scientific Expands Optical Measurement Capability for Laboratory Water and Wastewater Analysis

Friday 3 May,2013

Acceleron and Shire Conclude Collaboration on ACE-031

Friday 3 May,2013

Research and Markets: Effect of Sequestration on Pha/Bio Industry

Friday 3 May,2013

Rite Aid Reports Same Store Sales for April

Friday 3 May,2013

Research and Markets: Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2013

Friday 3 May,2013

Research and Markets: Diabetes Landscape: Market, Technology and Intellectual Property

Friday 3 May,2013

Liquidia Announces Plan to Form Ophthalmology Company to Support Product Development Strategy

Friday 3 May,2013

Gilead Reports Interim Data From Phase 2 LONESTAR Study

Friday 3 May,2013

Baron and Budd Now Handling Granuflo Recall Lawsuits

Friday 3 May,2013

Corgenix Expands Contract Services Business Unit

Friday 3 May,2013

PBS Biotech Signs Exclusive Distributorship with SCRUM for Japan

Friday 3 May,2013

Lil’ Drug Store Products Makes Category Management a snap!SM for Convenience Retailers

Friday 3 May,2013

IMPAX LABORATORIES 96 HOUR ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Lead Plaintiff Motion Deadline in Securities Class Action Lawsuit Against Impax Laboratories, Inc.

Friday 3 May,2013

BASi Launches Innovative Glucose Monitoring Project With Pinnacle Technology

Friday 3 May,2013

PHT Corporation President and CEO Philip Lee Chosen as Ernst & Young New England Region Entrepreneur of the Year Semi-Finalist

Friday 3 May,2013

Top Pharmaceutical Companies Bridge the Gap between Portfolio and Lifecycle Management

Friday 3 May,2013

Teva Reports First Quarter 2013 Results

Thursday 2 May,2013

Moving Liquids with Sound Helps Identify Drug Candidates that Traditional Lab Techniques Miss

Thursday 2 May,2013

Acorda Therapeutics Reports First Quarter 2013 Financial Results

Thursday 2 May,2013

Trading of AVEO Common Stock Halted

Thursday 2 May,2013

Harbor Island Development Corp. Signs Exclusive Marketing Agreement with House Brands, LLC. to Expand its Nationwide Media Campaign for Dynamic Male

Thursday 2 May,2013

InVivo Therapeutics Named a 2013 “Best Places to Work” Winner by Boston Business Journal

Thursday 2 May,2013

CYCLOSET (bromocriptine mesylate) Included in American Association of Clinical Endocrinologists Comprehensive Diabetes Management Algorithm

Thursday 2 May,2013

Incyte Reports First-Quarter 2013 Financial Results; Updates Shareholders on Key Clinical Programs

Thursday 2 May,2013

Arrowhead to Report Fiscal 2013 Second Quarter Financial Results

Thursday 2 May,2013

Foundation Medicine and Memorial Sloan-Kettering Cancer Center Announce Partnership to Advance Patient Care in Hematologic Cancers

Thursday 2 May,2013

Zalicus Reports Financial Results for the First Quarter 2013

Thursday 2 May,2013

Spectrum Pharmaceuticals Announces First Quarter 2013 Financial Results Teleconference and Webcast

Thursday 2 May,2013

Sanofi Q1 2013 - Interview with CFO Jérôme Contamine

Thursday 2 May,2013

Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants

Thursday 2 May,2013

Anika Therapeutics Reports First-Quarter 2013 Financial Results

Thursday 2 May,2013

Anacor Pharmaceuticals Announces Closing of $23 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Over-Allotment Option

Thursday 2 May,2013

BioForward Testifies in Support of Assembly Bill 181 and Increasing Pool of Capital in Wisconsin

Thursday 2 May,2013

PharMerica Reports Results for the First Quarter of 2013

Thursday 2 May,2013

Alkermes’ Corporate Presentation to be Webcast at the Bank of America Merrill Lynch 2013 Smid Cap Conference

Thursday 2 May,2013

Beware of Prescriptions Not Matching Pill Bottle Contents

Thursday 2 May,2013

Charles River Laboratories Announces First-Quarter 2013 Results from Continuing Operations

Thursday 2 May,2013

Symphogen Expands Previous Private Equity Round, Reaching a Total of € 141 million (USD 185 Million)

Thursday 2 May,2013

Coordinating Hospital Meal Delivery with Insulin Dosing Equals Better Outcomes for Diabetes Patients

Thursday 2 May,2013

The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies – Big or Small

Thursday 2 May,2013

Impax Laboratories Reports First Quarter 2013 Results

Thursday 2 May,2013

Forest Laboratories and Almirall Announce Positive Results for the Second Phase III Study for Aclidinium and Formoterol combination in COPD

Thursday 2 May,2013

PPD’s Reputation Ranked Best of all CROs in CenterWatch’s Global Survey of Clinical Research Sites

Thursday 2 May,2013

Genemarkers Proud Sponsor of the Rare Disease Challenge

Thursday 2 May,2013

Research and Markets: Diverticulitis Global Clinical Trials Review, H1, 2013

Thursday 2 May,2013

Seaside Therapeutics to Announce Results from a Phase 2b Clinical Trial of Arbaclofen in Autism Spectrum Disorder at the International Meeting for Autism Research (IMFAR) 2013 Conference

Thursday 2 May,2013

Ferring to Present Safety Analysis for FIRMAGON® (degarelix) at the American Urological Association Annual Meeting

Thursday 2 May,2013

Research and Markets: Japan Pharmaceutical Market Outlook

Wednesday 1 May,2013

Rite Aid Returns to Entertainment Industry Foundation Revlon Run/Walk For Women as Platinum Sponsor

Wednesday 1 May,2013

California health system Joins the Premier healthcare alliance to Improve Care Quality and Costs

Wednesday 1 May,2013

Novella Clinical Expands West Coast Business Development Team

Wednesday 1 May,2013

Research and Markets: 2013 Japanese Hospital Cancer Diagnostics Market

Wednesday 1 May,2013

Research and Markets: Appendicitis Global Clinical Trials Review, H1, 2013

Wednesday 1 May,2013

Research and Markets: Hyperphosphatemia Global Clinical Trials Review, H1, 2013

Wednesday 1 May,2013

Research and Markets: Gram-Positive Bacterial Infections - Pipeline Review, H1 2013

Wednesday 1 May,2013

Research and Markets: Rabies - Pipeline Review, H1 2013

Wednesday 1 May,2013

Research and Markets: Dystonia Global Clinical Trials Review, H1, 2013

Wednesday 1 May,2013

Inventors Honored for Bringing Life-Saving Health Solutions to the Developing World

Wednesday 1 May,2013

Lantheus Medical Imaging to Proceed with Flurpiridaz F 18 Phase 3 Clinical Program Based on Interim Analysis of Data from First Phase 3 Study

Wednesday 1 May,2013

NPS Pharmaceuticals to Report First Quarter 2013 Financial Results

Wednesday 1 May,2013

Research and Markets: Burns - Pipeline Review, H1 2013

Wednesday 1 May,2013

Medgenics Announces Results of 2013 Annual Meeting of Stockholders

Wednesday 1 May,2013

Fluidigm to Develop and Supply a Custom High-throughput Prep System for HLA Typing

Wednesday 1 May,2013

pSivida Corp. Announces New ILUVIEN® PDUFA Date of October 17, 2013

Wednesday 1 May,2013

Lucigen Corporation and Research Corporation Technologies Announce Partnership and Launch of the Endotoxin free CleanColi™ Expression System

Wednesday 1 May,2013

Amarantus Posts Review of MANF Literature to Web Site

Wednesday 1 May,2013

Archimedes, Inc. Collaborates with HHS and CMS to Provide Researchers and Software Developers Unprecedented Access to Health Data

Wednesday 1 May,2013

Allergan Reports First Quarter 2013 Operating Results

Wednesday 1 May,2013

ArQule to Report First Quarter 2013 Financial Results on May 8, 2013

Wednesday 1 May,2013

Merck Announces First-Quarter 2013 Financial Results

Wednesday 1 May,2013

Research and Markets: 2013 European Infectious Disease Testing Market: France, Germany, Italy, Spain, UK - Emerging Opportunities and Business Expansion Strategies

Wednesday 1 May,2013

Merck Announces New $15 Billion Share Repurchase Program

Wednesday 1 May,2013

Research and Markets: Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review, H1, 2013

Wednesday 1 May,2013

Elixir Medical Corporation to Announce 6-month Results of the DESolve Fully Bioresorbable Coronary Scaffold System Pivotal Trial at Late Breaking Trial Session of EuroPCR

Wednesday 1 May,2013

H7N9: Greffex “Beats the Clock” to Build the First Comprehensive H7N9 Vaccine

Wednesday 1 May,2013

ImmunoCellular Therapeutics to Report Financial Results for the First Quarter 2013 May 9, 2013

Wednesday 1 May,2013

Tau Founder Dr. Timothy L. Macdonald Honored for Contributions to Virginia Bioscience

Wednesday 1 May,2013

Antares Pharma to Host First Quarter 2013 Operating and Financial Results Conference Call

Wednesday 1 May,2013

Navidea Biopharmaceuticals Announces the U.S. Launch of Lymphoseek®

Wednesday 1 May,2013

Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call

Wednesday 1 May,2013

Xtalks Announces Its May 2013 Life Sciences Webinar Calendar

Wednesday 1 May,2013

Walgreens Celebrates Boston Flagship Store Opening with Ribbon Cutting

Wednesday 1 May,2013

NTRR Initiates Talks With Potential Partners in California’s Booming Medical Marijuana Market

Wednesday 1 May,2013

New evidence to be presented in Systagenix symposium at EWMA 2013 confirms EPA to be highly predictive of skin graft failure

Wednesday 1 May,2013

Cure Duchenne Hosts Drisapersen Update Webinar With GSK on May 6, 2013

Wednesday 1 May,2013

FDA Approves Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for Consumers 15 and Over

Wednesday 1 May,2013

Celator® Pharmaceuticals Raises $32.5 Million Completing a $39.3 Million Private Placement Financing

Wednesday 1 May,2013

BioNJ To Host 2ND Annual Life Sciences Industry HR Conference on May 20

Wednesday 1 May,2013

Vertex Reports First Quarter 2013 Financial Results and Reviews Recent Progress in Development Programs for Cystic Fibrosis and Hepatitis C

Wednesday 1 May,2013

Affymetrix Reports 2013 First Quarter Results

Wednesday 1 May,2013

Wingspan Technology’s Wingspan TMF for iPad is Now Available in the Apple App Store

Wednesday 1 May,2013

Research and Markets: Covidien plc (COV) - Product Pipeline Analysis, 2013 Update Available Now for Analysis

Wednesday 1 May,2013

Lannett Announces Preliminary Fiscal 2013 Third Quarter Net Sales of $39 Million, Earnings Per Share between $0.12 and $0.14

Wednesday 1 May,2013

Emergent BioSolutions Participates in NATO Defense against Terrorism Workshop at the Counter Terror Expo in London

Wednesday 1 May,2013

Central Nervous System Market Examined in Insightful Global Industry Analysts Report Available at MarketPublishers.com

Wednesday 1 May,2013

FDA Approves ACTEMRA® for Children Living with a Rare Form of Arthritis

Wednesday 1 May,2013

Biologics Introduces Clinical Policy and Therapeutic Intelligence Office

Wednesday 1 May,2013

Research and Markets: Dementia Associated With Alzheimers Disease - Pipeline Review, H1 2013 Contains News and Deals Relating to Products

Wednesday 1 May,2013

Research and Markets: Chinese Markets for Anaesthetic Drugs 2013 Report Features Players such as Shandong KeYuan Pharmaceutical Co.,Ltd

Wednesday 1 May,2013

Research and Markets: Chinese Markets for Colon Cancer Treatment Drugs: 2016-2021 Forecasts Out Now

Wednesday 1 May,2013

Oragenics To Present Oral Care Probiotics Seminar at SupplySide MarketPlace 2013

Wednesday 1 May,2013

SQI Announces Private Placement of up to CDN $3.760 Million

Wednesday 1 May,2013

Research and Markets: Diphtheria - Pipeline Review, H1 2013

Wednesday 1 May,2013

GREER® Laboratories, Inc. Completes Deal with Ares Life Sciences

Wednesday 1 May,2013

Walgreens Celebrates Boston Flagship Store Opening with Ribbon Cutting

Wednesday 1 May,2013

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.10

Wednesday 1 May,2013

Allergan Announces Death of Stephen J. Ryan, M.D.

Wednesday 1 May,2013

Walgreens to Debut Boston Flagship Store on May 1 at Corner of School and Washington

Wednesday 1 May,2013

Ceiba Solutions Enables R&D Laboratories to Meet Increasingly Complex IT and Information Management Challenges

Wednesday 1 May,2013

ACADIA Pharmaceuticals to Announce First Quarter 2013 Financial Results on May 7, 2013

Wednesday 1 May,2013

KILL FDA Accepts Octapharma USA Biological License Application for octaplex® – an Investigational 4-Factor PCC

Wednesday 1 May,2013